Literature DB >> 33623130

Strong and sustainable primary healthcare is associated with a lower risk of hospitalization in high risk patients.

Olga A Sawicki1, Angelina Mueller2, Renate Klaaßen-Mielke3, Anastasiya Glushan2, Ferdinand M Gerlach2, Martin Beyer2, Michel Wensing4, Kateryna Karimova2.   

Abstract

In 2004, Germany introduced a program based on voluntary contracting to strengthen the role of general practice care in the healthcare system. Key components include structured management of chronic diseases, coordinated access to secondary care, data-driven quality improvement, computerized clinical decision-support, and capitation-based reimbursement. Our aim was to determine the long-term effects of this program on the risk of hospitalization of specific categories of high-risk patients. Based on insurance claims data, we conducted a longitudinal observational study from 2011 to 2018 in Baden-Wuerttemberg, Germany. Patients were assigned to one or more of four open cohorts (in 2011, elderly, n = 575,363; diabetes mellitus, n = 163,709; chronic heart failure, n = 82,513; coronary heart disease, n = 125,758). Adjusted for key patient characteristics, logistic regression models were used to compare the hospitalization risk of the enrolled patients (intervention group) with patients receiving usual primary care (control group). At the start of the study and throughout long-term follow-up, enrolled patients in the four cohorts had a lower risk of all-cause hospitalization and ambulatory, care-sensitive hospitalization. Among patients with chronic heart failure and coronary heart disease, the program was associated with significantly reduced risk of cardiovascular-related hospitalizations across the eight observed years. The effect of the program also increased over time. Over the longer term, the results indicate that strengthening primary care could be associated with a substantial reduction in hospital utilization among high-risk patients.

Entities:  

Year:  2021        PMID: 33623130      PMCID: PMC7902818          DOI: 10.1038/s41598-021-83962-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  1 in total

1.  The development of diabetes complications in GP-centered healthcare.

Authors:  Kateryna Karimova; Lorenz Uhlmann; Marc Hammer; Corina Guethlin; Ferdinand M Gerlach; Martin Beyer
Journal:  Am J Manag Care       Date:  2018-07       Impact factor: 2.229

  1 in total
  4 in total

1.  General practitioner-centred paediatric primary care reduces risk of hospitalisation for mental disorders in children and adolescents with ADHD: findings from a retrospective cohort study.

Authors:  Angelina Mueller; Olga A Sawicki; Moritz Philipp Günther; Anastasiya Glushan; Claudia Witte; Renate Klaaßen-Mielke; Ferdinand M Gerlach; Martin Beyer; Kateryna Karimova
Journal:  Eur J Gen Pract       Date:  2022-12       Impact factor: 3.636

2.  Information exchange networks for chronic diseases in primary care practices in Germany: a cross-sectional study.

Authors:  Christine Arnold; Patrick Hennrich; Michel Wensing
Journal:  BMC Prim Care       Date:  2022-03-28

3.  Differences in opioid prescription rates between patients with musculoskeletal disorders enrolled in coordinated ambulatory healthcare and patients receiving usual care: a retrospective observational cohort study.

Authors:  Angelina Müller; Olga Anastasia Amberger; Anastasiya Glushan; Renate Klaaßen-Mielke; Claudia Witte; Marjan van den Akker; Robin Brünn; Ferdinand M Gerlach; Martin Beyer; Kateryna Karimova
Journal:  BMJ Open       Date:  2022-08-08       Impact factor: 3.006

4.  Evaluation of a collaborative ambulatory orthopedic care program for patients with hip and knee osteoarthritis: a comparative observational cohort study.

Authors:  Angelina Müller; Olga A Amberger; Anastasiya Glushan; Claudia Witte; Renate Klaaßen-Mielke; Burkhard Lembeck; Martin Beyer; Ferdinand M Gerlach; Kateryna Karimova
Journal:  BMC Musculoskelet Disord       Date:  2022-08-03       Impact factor: 2.562

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.